Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been selected as a 2012 fellow with the American Society of Clinical Oncology (ASCO).
One of just 11 oncologists awarded the lifetime recognition for 2012, Kelly is being recognized for her "extraordinary volunteer service, dedication and commitment to ASCO," work that benefits the oncology specialty and the patients they serve. Kelly was given the award during ASCO's annual meeting held in Chicago earlier this month.
"I am humbled to have been selected for this recognition by my peers," Kelly said of the award. "Serving ASCO these past 20 years has been an honor, and I look forward to fulfilling my role as an ASCO fellow for the benefit of all cancer patients for many years to come."
Kelly's participation in ASCO began with her membership in 1990. Since then, she has served and held leadership roles on numerous committees, including the Program Committee, Publication Committee, Educational Committee and the Cancer Prevention Committee, among other contributions.
Kelly joined the UC Davis Comprehensive Cancer Center in January 2011 as a professor of medicine in the Division of Hematology and Oncology. A recognized lung cancer expert at the forefront of evaluating anticancer agents, Kelly is building the cancer center's phase I clinical trials program and continues to see patients in the oncology clinic.
Until this year, the Fellow of the American Society of Clinical Oncology (FASCO) award was called the ASCO Statesman Award. David Gandara, Senior Advisor for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center, was given ASCO's Statesman Award in 2008.
ASCO is the world's leading professional organization comprising 30,000 specialists from across oncology disciplines who care for patients with cancer. ASCO members set the standard of patient care worldwide, and lead efforts to increase funding for cancer research and ultimately find cures for different types of cancer. The non-profit organization publishes the Journal of Clinical Oncology (JCO), the preeminent, peer-reviewed, medical journal on clinical cancer research.
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 9,000 adults and children every year, and access to more than 150 clinical trials at any given time. Its innovative research program engages more than 280 scientists at UC Davis, Lawrence Livermore National Laboratory and Jackson Laboratory (JAX West), whose scientific partnerships advance discovery of new tools to diagnose and treat cancer. Through the Cancer Care Network, UC Davis collaborates with a number of hospitals and clinical centers throughout the Central Valley and Northern California regions to offer the latest cancer care. Its community-based outreach and education programs address disparities in cancer outcomes across diverse populations. For more information, visit cancer.ucdavis.edu.